Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000514865 | SCV000293047 | likely benign | not provided | 2021-04-06 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25025039, 32376792) |
Illumina Laboratory Services, |
RCV000348006 | SCV000373795 | uncertain significance | Autosomal recessive distal spinal muscular atrophy 1 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Center for Pediatric Genomic Medicine, |
RCV000514865 | SCV000610077 | uncertain significance | not provided | 2017-03-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082293 | SCV000764349 | likely benign | Autosomal recessive distal spinal muscular atrophy 1; Charcot-Marie-Tooth disease axonal type 2S | 2025-01-15 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173331 | SCV001336419 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV000514865 | SCV002047795 | likely benign | not provided | 2021-06-17 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000514865 | SCV002062995 | likely benign | not provided | 2021-10-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002450728 | SCV002735748 | uncertain significance | Inborn genetic diseases | 2021-12-15 | criteria provided, single submitter | clinical testing | The p.P787L variant (also known as c.2360C>T), located in coding exon 13 of the IGHMBP2 gene, results from a C to T substitution at nucleotide position 2360. The proline at codon 787 is replaced by leucine, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV000514865 | SCV003813310 | uncertain significance | not provided | 2020-02-05 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000514865 | SCV004226198 | uncertain significance | not provided | 2023-04-11 | criteria provided, single submitter | clinical testing |